Structure |
Chemical Name |
CAS |
MF |
|
8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one |
31251-41-9 |
C14H10ClNO |
|
(R)-Ornidazole |
166734-80-1 |
C7H10ClN3O3 |
|
Bendamustine Related Impurity 22 |
|
|
|
Bendamustine Related Impurity 9 |
|
|
|
Edoxaban Impurity 20 (1R,2R,4S) |
1928729-31-0 |
C16H29N3O7 |
|
Edoxaban Impurity 40 |
2081883-52-3 |
C14H27N3O3 |
|
Everolimus Impurity 2 |
|
|
|
Levosimendan Impurity 2 (Mixture ofZandEIsomers) |
|
|
|
N-(2,3-Dichloro-phenyl)-N'-[2-(2,3-dichloro-phenylamino)-ethyl]-ethane-1,2-diamine |
|
C16H17Cl4N3 |
|
N-(2,3-Dichloro-phenyl)-N'-[2-(2,3-dichloro-phenylamino)-ethyl]-ethane-1,2-diamine |
|
C16H17Cl4N3 |
|
Solifenacin Related Compound 29 |
861998-77-8 |
C23H26N2O3 |
|
Ticagrelor Impurity 31 |
|
|
|
Ticagrelor Related Compound 46 |
2205903-73-5 |
C28H42ClN9O8S2 |
|
Ticagrelor Related Compound 71 |
1548397-10-9 |
C7H8ClN3O3S |
|
Ticagrelor Related Compound 76 |
|
|
|
Vonoprazan Impurity 25 |
|
|
|
1-(3,4-Dimethoxyphenyl)-2-(methylsulfonyl)ethan-1-amine |
1255909-25-1 |
C11H17NO4S |
|
Adefovir Impurity C |
|
|
|
C-Desmethyl Metoprolol |
109632-08-8 |
C14H23NO3 |
|
JZWUWLJCMMPASK-YTSMVRMISA-N |
147103-95-5 |
C24H24N4O7S |
|
KXEITTOLAUJQPU-UHFFFAOYSA-N |
1797832-43-9 |
C20H21N7O2S |
|
GPZGXSFHPLUMHE-KEUNHQLVSA-N |
157054-84-7 |
C52H81NO13 |
|
IRLGOHSHDYCIAB-ZMVBZRCWSA-N |
1076198-14-5 |
C19H23F3N2O5 |
|
AOEGVETYSHPGBP-XYIDDFOTSA-N |
1887057-05-7 |
C41H55NO14 |
|
4,6-DIAMINOINDAZOLE |
885518-52-5 |
C7H8N4 |
|
12-Deoxy Roxithromycin |
425365-65-7 |
C41H76N2O14 |
|
1-(1-oxidopyridin-1-ium-2-yl)-1-phenylethanol |
100393-43-9 |
C13H13NO2 |
|
(R)-(R)-1-methylpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate(WXC03446) |
616866-21-8 |
C18H25NO3 |
|
(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzoic acid |
|
C18H22N4O4 |
|
(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzoic acid |
|
C18H22N4O4 |
|
6'-methyl-3-(4-(methylsulfonyl)phenyl)-[2,3'-bipyridin]-5-amine |
|
C18H17N3O2S |
|
Diquafosol Impurity 4 |
|
|
|
Tofacitinib Impurity X |
|
|
|
3-pentylideneisobenzofuran-1(3H)-one |
90965-68-7 |
C13H14O2 |
|
Labetalol EP impurity E |
|
|
|
1-Propanol, 3-(2-methoxy-5-nitrophenoxy)- |
1156068-41-5 |
C10H13NO5 |
|
Blonanserin Impurity M |
|
|
|
Brexpiprazole Impurity H |
|
|
|
Cefaclor EP Impurity H |
|
|
|
Flupentixol Impurity B |
|
|
|
Ipratropium Bromide Impurity J |
|
C20H29Br2NO3 |
|
2-(5-Acetyl-2-ethoxyphenyl)-5-methyl-7-propyl-imidazo[5,1-f][1,2,4]triazin-4(1H)-one |
358390-43-9 |
C19H22N4O3 |
|
Empagliflozin Impurity 80 |
|
|
|
Empagliflozin Impurity 92 |
|
|
|
Iohexol Impurity N |
|
|
|
Pitavastatin 5-Oxo Impurity Calcium Salt |
2180095-22-9 |
C25H24CaFNO4 |
|
1-(2-bromo-3,5-dihydroxyphenyl)ethanone |
2092614-65-6 |
C8H7BrO3 |
|
Lenvatinib impurity LFZZ-18 |
|
C11H8Cl2N2O2 |
|
Rosuvastatin Impurity 121 |
140164-51-8 |
C10H18O5 |
|
Brivaracetam Impurity 38 |
|
|
|
Isavuconazole Impurities 04 |
|
|
|
Ticagrelor Impurity 119 |
|
|
|
Ticagrelor Impurity 118 |
|
|
|
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-, acetate (9CI) |
402508-35-4 |
C11H18O6 |
|
L-Alanine, 3-[(S)-(carboxymethyl)sulfinyl]- |
112246-66-9 |
C5H9NO5S |
|
2-Propanone, 1-[4,5-dihydro-2-(4-methyl-1-piperazinyl)-4-thioxo-3H-1,5-benzodiazepin-3-ylidene]- |
1902955-67-2 |
C17H20N4OS |
|
3(2H)-Pyridazinone, 6-[4-(ethylamino)phenyl]-4,5-dihydro-5-methyl- |
52240-42-3 |
C13H17N3O |
|
Benzoic acid, 4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]- |
938143-02-3 |
C14H18N2O3 |
|
1-(4-methylbenzyl)-1,4,8,11-tetraazacyclotetradecane tetrahydrochloride |
|
|
|
2,4-bis(1-(2,3-dimethylphenyl)ethyl)-1H-imidazole |
|
|
|
2-((4R,6S)-6-((2-((4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetoxy)methyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid |
|
|
|
1,3-bis(4-((E)-3-methoxy-3-oxoprop-1-en-1-yl)benzyl)-1H-imidazol-3-ium bromide |
|
|
|
Crisaborole intermediate |
1187230-70-1 |
C14H14BNO3 |
|
Glycine, (2R)-N-[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]-2-phenylglycyl-2-[(2S,4S)-4-carboxy-5,5-dimethyl-2-thiazolidinyl]-, (2R)- |
1449784-97-7 |
C23H29N5O8S |
|
6-Quinolinecarboxamide, 4-[(2-chloro-4-hydroxyphenyl)amino]-7-methoxy- |
2380197-89-5 |
C17H14ClN3O3 |
|
1-Pyrrolidineacetic acid, α-ethyl-2-oxo-4-propyl-, methyl ester, (4R)- |
930123-52-7 |
C12H21NO3 |
|
Traxipide impurity |
|
|
|
Benzeneacetic acid, 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethyl-, methyl ester |
1181267-38-8 |
C29H39N3O3 |
|
Benzenemethanol, 4-[2-(1-methylethoxy)ethoxy]- |
1039828-27-7 |
C12H18O3 |
|
Brivaracetam Impurity 7 HCl |
357338-46-6 |
C13H27ClN2O3 |
|
Bisacodyl Impurity 1 |
13004-51-8 |
C18H15NO2 |
|
Vecuronium Bromide ImpurityACDEFGHJKL |
|
|
|
Butanedioic acid, 2-[[2-methyl-1-(phenylmethyl)-1H-imidazol-5-yl]methylene]-, 1-ethyl ester, (2E)- |
1640981-02-7 |
C18H20N2O4 |
|
INDEX NAME NOT YET ASSIGNED |
2452300-94-4 |
C21H25ClO8 |
|
1-Butanone, 1-(4-fluorophenyl)-4-[(6bS,10aS)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]- |
1576240-15-7 |
C24H28FN3O |
|
1-Pyrrolidineacetamide, α-ethyl-4-(1-methylethyl)-2-oxo-, (αS,4S)- |
357334-83-9 |
C11H20N2O2 |
|
impurity 42 |
|
|
|
2,2'-(4,10-bis((2S,3R)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid |
|
|
|
Loratadine Impurity 2 |
167891-69-2 |
C22H25ClN2O2 |
|
Eliglustat (1S,2S)-Isomer (Hemitartrate) |
1092472-70-2 |
C23H36N2O4 |
|
3-Azetidineacetic acid, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]- |
2271228-52-3 |
C16H18N6O4S |
|
Cyclopentanecarboxylic acid, 3-[(1S)-1-amino-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-, (1S,2S,3S,4R)- |
2412376-06-6 |
C13H26N4O3 |
|
Peramivir Impurity 49 |
2758048-81-4 |
|
|
Peonidin-3-O-Sophoroside-
5-O-β-D-glucoside |
81360-22-7 |
C34H43O21+ |
|
1-Pyrrolidinecarboxylic acid, 3,3'-dithiobis[5-[[(3-carboxyphenyl)amino]carbonyl]-, 1,1'-bis[(4-nitrophenyl)methyl] ester, (3S,3'S,5S,5'S)- |
1401451-19-1 |
C40H36N6O14S2 |
|
Benzeneacetic acid, α-(hydroxymethyl)-, 9-butyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl ester, [7(S)-(1α,2β,4β,5α,7β)]- (9CI) |
14861-14-4 |
C20H27NO4 |
|
Avatrombopag Impurity 32 |
|
|
|
Cisatracurium besylate impurity 18 |
|
|
|
Paclitaxel Impurity1 ABCDEFGHJKL |
|
|
|
3-THIOPHENEPROPANAMINE, N,N-DIMETHYL-GAMMA-(1-NAPHTHALENYLOXY)-, ETHANEDIOATE(1:1) |
116817-26-6 |
C21H23NO5S |
|
(2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol |
182230-43-9 |
C16H14F3N5O |
|
Bumetanide Impurity 8 |
|
|
|
Benzenesulfonamide, N-(2-aminoethyl)-3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxy- |
448184-52-9 |
C19H26N6O4S |
|
Avibactam Impurity 04 |
|
|
|
Latamoxef Impurity C |
|
|
|
Carbamic acid, [2-hydroxy-1-methyl-2-[3-(phenylmethoxy)phenyl]ethyl]-, phenylmethyl ester, [R-(R*,S*)]- (9CI) |
31301-86-7 |
C24H25NO4 |
|
9H-Purine-9-ethanol, 6-amino-β-methyl- |
20776-34-5 |
C8H11N5O |
|
2-amino-5-[(3,4,5-trimethoxyphenyl)methyl]-1H-pyrimidin-4-one |
92440-76-1 |
C14H17N3O4 |
|
Edoxaban impurity ABCDEFGHJKL |
|
|
|
(S)-3-(3-((3-chloro-2-(3,4-dimethoxyphenyl)propyl)(methyl)amino) propyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one hydrochloride |
|
|